Valuation: CeriBell, Inc.

Market Cap 901M 805M 751M 682M 1.28B 87.27B 1.3B 9.01B 3.53B 44.35B 3.38B 3.31B 143B P/E 2026 *
-11.9x
P/E 2027 * -14.6x
Enterprise Value 906M 809M 755M 686M 1.29B 87.74B 1.3B 9.06B 3.54B 44.59B 3.4B 3.33B 143B EV / Sales 2026 *
7.85x
EV / Sales 2027 * 6.33x
Free-Float
88.16%
Yield 2026 *
-
Yield 2027 * -
1 day-2.81%
1 week-3.43%
Current month-6.52%
1 month-6.21%
3 months+17.53%
6 months+22.06%
Current year+3.97%
1 week 22.62
Extreme 22.62
25.1
1 month 22.62
Extreme 22.62
25.63
Current year 15.84
Extreme 15.84
25.63
1 year 10.85
Extreme 10.85
25.63
3 years 10.01
Extreme 10.01
32.75
5 years 10.01
Extreme 10.01
32.75
10 years 10.01
Extreme 10.01
32.75
Manager TitleAgeSince
Chief Executive Officer 46 2015-09-30
Director of Finance/CFO 44 2020-03-31
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Director/Board Member 46 2014-08-28
Chairman 57 2014-08-28
Director/Board Member 64 2021-03-31
Date Insider Type Main position Quantity % Market Cap. Importance
10/1/26 Exercice

Chief Technology Officer

14,661 0.0382%
9/15/26 Exercice

Chief Financial Officer

2,538 0.0066%
9/15/26 Sell

Founder

-20,846 0.0543%
Change 5-day change 1-year change 3-year change Capi.($)
-2.81%-3.43%+86.27% - 901M
-3.26%-2.08%+19.16%+28.78% 245B
-2.23%+0.47%+3.80%-2.57% 154B
-0.03%+3.32%-7.48%+40.78% 146B
-0.04%-3.70%-56.99%-20.55% 60.26B
-3.77%-2.79%+9.33%+13.59% 49.44B
-2.58%-1.46%+16.65%+47.60% 47.67B
-0.78%+1.73%-21.18%-18.56% 48.04B
+0.17%+0.09%-6.50%+32.37% 45.74B
-2.63%-0.45%+29.29%+58.66% 42.84B
Average -1.78%-1.93%+7.24%+20.01% 83.97B
Weighted average by Cap. -1.90%-2.10%+2.40%+20.77%

Financials

2026 *2027 *
Net sales 115M 103M 96.2M 87.39M 164M 11.18B 166M 1.15B 452M 5.68B 434M 424M 18.28B 147M 131M 123M 111M 209M 14.24B 211M 1.47B 575M 7.24B 552M 540M 23.28B
Net income -75.94M -67.82M -63.27M -57.47M -108M -7.36B -109M -760M -297M -3.74B -285M -279M -12.02B -64M -57.15M -53.31M -48.43M -91.13M -6.2B -92.02M -640M -250M -3.15B -240M -235M -10.13B
Net Debt 4.85M 4.33M 4.04M 3.67M 6.9M 469M 6.97M 48.48M 18.96M 239M 18.2M 17.8M 767M 29.76M 26.57M 24.79M 22.52M 42.38M 2.88B 42.79M 298M 116M 1.46B 112M 109M 4.71B
Projected Income Statement - Annual - CeriBell, Inc.
Logo CeriBell, Inc.
CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. It has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its hardware is composed of disposable, flexible headbands and head caps (Wearables) and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals. EEG data captured by the recorder are interpreted by its proprietary AI-powered seizure detection algorithms, which monitor the patient’s EEG signal and support the clinician’s real-time assessment of seizure activity.
Employees
327
Date Price Change Volume
26-10-08 US$22.80 -2.90% 88,795
26-10-07 US$23.48 -3.53% 305,400
26-10-06 US$24.34 -2.09% 241,740
26-10-05 US$24.86 +4.94% 239,505
26-10-02 US$23.69 +0.34% 307,031
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Ratings Surperformance© - CeriBell, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
23.48USD
Average target price
28.57USD
Spread / Average Target
+21.68%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CeriBell, Inc.
  1. Stock Market
  2. Stocks
  3. CBLL Stock